Literature DB >> 16831511

Precystectomy nomogram for prediction of advanced bladder cancer stage.

Pierre I Karakiewicz1, Shahrokh F Shariat, Ganesh S Palapattu, Paul Perrotte, Yair Lotan, Craig G Rogers, Gilad E Amiel, Amnon Vazina, Amit Gupta, Patrick J Bastian, Arthur I Sagalowsky, Mark Schoenberg, Seth P Lerner.   

Abstract

OBJECTIVE: To evaluate precystectomy prediction of pT and pN stages at cystectomy.
METHODS: Multivariate logistic regression analyses modelled variables of 726 evaluable patients treated with radical cystectomy and bilateral pelvic lymphadenectomy. The first set of models predicted pT(3-4) stage at cystectomy, and the second set predicted pN(1-3) stages at cystectomy. Transurethral resection (TUR) predictors consisted of 2002 T stage, 1973 WHO tumour grade, presence of carcinoma in situ, age, gender, and delivery of neo-adjuvant chemotherapy. The area under the ROC curve quantified nomogram accuracy. Two hundred bootstrap resamples were used to reduce overfit bias.
RESULTS: At TUR, 11% of patients were staged as pT(3-4) versus 42% at cystectomy. Lymph node metastases were found in 24% of patients at cystectomy (pN(1-3)). The multivariate pT(3-4) nomogram was 75.7% accurate versus 71.4% for TUR T stage. The multivariate pN(1-3) nomogram was 63.1% accurate versus 61.0% for TUR T stage.
CONCLUSION: Multivariate nomograms are not perfect, but they do predict more accurately than TUR T stage alone.

Entities:  

Mesh:

Year:  2006        PMID: 16831511     DOI: 10.1016/j.eururo.2006.06.010

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  45 in total

1.  [Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens].

Authors:  M May; H-M Fritsche; S Brookman-May; M Burger; C Bolenz; L Trojan; E Herrmann; M S Michel; C Wülfing; A Tiemann; S C Müller; J Ellinger; A Buchner; C G Stief; D Tilki; W F Wieland; C Gilfrich; T Höfner; M Hohenfellner; A Haferkamp; J Roigas; M Zacharias; S Gunia; P J Bastian
Journal:  Urologe A       Date:  2010-12       Impact factor: 0.639

Review 2.  The prognostic role of lymphovascular invasion in urothelial carcinoma of the bladder.

Authors:  Romain Mathieu; Ilaria Lucca; Morgan Rouprêt; Alberto Briganti; Shahrokh F Shariat
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

Review 3.  Neoadjuvant chemotherapy for invasive bladder cancer.

Authors:  Guru Sonpavde; Cora N Sternberg
Journal:  Curr Urol Rep       Date:  2012-04       Impact factor: 3.092

Review 4.  [The likelihood ratio: estimation of the impact of a diagnostic test on treatment decision].

Authors:  L A Kluth; M Rink; F K H Chun; M Fisch; S F Shariat; P Dahm
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

5.  Perioperative chemotherapy for muscle-invasive bladder cancer.

Authors:  Peter Black; Alan So
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 6.  Use of nomograms as predictive tools in bladder cancer.

Authors:  Ahmad Shabsigh; Bernard H Bochner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 7.  Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.

Authors:  Richard J Sylvester
Journal:  Scand J Urol Nephrol Suppl       Date:  2008-09

Review 8.  Bladder cancer.

Authors:  David J Gallagher; Matthew I Milowsky
Journal:  Curr Treat Options Oncol       Date:  2009-08

Review 9.  A systematic review of the tools available for predicting survival and managing patients with urothelial carcinomas of the bladder and of the upper tract in a curative setting.

Authors:  Sarah J Drouin; David R Yates; Vincent Hupertan; Olivier Cussenot; Morgan Rouprêt
Journal:  World J Urol       Date:  2012-12-18       Impact factor: 4.226

10.  Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy.

Authors:  Kamran Zargar-Shoshtari; Homayoun Zargar; Colin P Dinney; Cesar E Ercole; Pranav Sharma; Evan Kovac; Petros D Grivas; Andrew J Stephenson; Jay B Shah; Peter C Black; Philippe E Spiess
Journal:  World J Urol       Date:  2015-08-19       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.